Biolase Inc COM PAR $.001 NEW Azioni (OTC: BIOL)

Ultime notizie per Biolase Inc COM PAR $.001 NEW (OTC:BIOL) Azioni

Biolase

Biolase Inc COM PAR $.001 NEW

Biolase Inc

BIOLIFE4D CORP

BIOLINGUS (CAYMAN) LIMITED

BioLargo Inc

BioLife Solutions Inc

BioLineRx Ltd. - American Depositary Shares

BioLine Rx Ltd

BIOLIFE SCIENCES INC by BIOLIFE SCIENCES INC.

Biolife Sciences Inc

Biolog-id

Benchmark analyst Bruce Jackson reiterates Biolase (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#OTC">BIOL</a>) with a Speculative Buy and maintains $0.4 price target.

News

Price Target

Reiteration

Analyst Ratings

BIOL

Benchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price Target

Ascendiant Capital analyst Edward Woo maintains Biolase (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#OTC">BIOL</a>) with a Buy and lowers the price target from $3.5 to $2.

Ascendiant Capital Maintains Buy on Biolase, Lowers Price Target to $2

<h3>Gainers</h3>
<ul>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) stock increased by 48.1% to $1.54 during Wednesday's after-market session. The company's market cap stands at $11.4 million. </li>
<li>Tempest Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) stock moved upwards by 40.0% to $3.99. The market value of their outstanding shares is at $88.6 million. </li>
<li>ASLAN Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLN#NASDAQ">ASLN</a>) stock increased by 18.51% to $0.37. The market value of their outstanding shares is at $8.3 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) shares increased by 15.18% to $0.9. The company's market cap stands at $15.2 million. </li>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) stock rose 13.15% to $2.15. The market value of their outstanding shares is at $5.4 million. </li>
<li>SAB Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) stock moved upwards by 8.94% to $2.8. The market value of their outstanding shares is at $25.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock fell 15.5% to $0.11 during Wednesday's after-market session. The company's market cap stands at $3.6 million. </li>
<li>Castle Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) shares declined by 10.77% to $19.82. The company's market cap stands at $547.1 million. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares fell 10.59% to $0.76. The company's market cap stands at $21.4 million. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock decreased by 9.53% to $2.47. The market value of their outstanding shares is at $13.3 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) shares declined by 8.5% to $3.88. The company's market cap stands at $3.8 million. </li>
<li>BIMI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) stock declined by 7.41% to $1.25. The company's market cap stands at $17.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ASLN

BIMI

CSTL

EVAX

GOVX

MBIO

SABS

SNGX

TLPH

Tempest Therapeutics, Inc. - Common Stock

TPST

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Sonoma Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) shares rose 60.2% to $0.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.2 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) stock moved upwards by 31.21% to $0.98. The market value of their outstanding shares is at $27.7 million. </li>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) shares increased by 24.32% to $1.38. The market value of their outstanding shares is at $3.4 million. </li>
<li>Silk Road Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILK#NASDAQ">SILK</a>) stock increased by 23.67% to $26.8. The company's market cap stands at $1.0 billion. </li>
<li>Onconetix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) shares rose 18.91% to $0.19. The market value of their outstanding shares is at $4.2 million. </li>
<li>Qualigen Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLGN#NASDAQ">QLGN</a>) stock increased by 17.84% to $0.21. The market value of their outstanding shares is at $1.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>DermTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMTK#NASDAQ">DMTK</a>) shares declined by 66.6% to $0.11 during Wednesday's pre-market session. The company's market cap stands at $3.8 million. </li>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock fell 37.02% to $0.09. The market value of their outstanding shares is at $3.1 million. </li>
<li>Zentalis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZNTL#NASDAQ">ZNTL</a>) shares fell 25.51% to $6.25. The company's market cap stands at $443.8 million. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) shares decreased by 16.56% to $0.2. The company's market cap stands at $5.6 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) stock fell 10.49% to $0.68. The market value of their outstanding shares is at $1.8 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) stock decreased by 10.42% to $2.15. The company's market cap stands at $13.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AZTR

DMTK

LGVN

ONCO

Qualigen Therapeutics, Inc. - Common Stock

QLGN

SILK

SNOA

VRPX

ZNTL

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

WIIM

Biolase shares are trading lower after the company announced that it will delist from the Nasdaq.

<h3>Gainers</h3>
<ul>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) shares rose 55.8% to $1.62 during Tuesday's after-market session. The market value of their outstanding shares is at $12.0 million. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock rose 14.74% to $0.4. The company's market cap stands at $2.1 million. </li>
<li>Oncology Institute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOI#NASDAQ">TOI</a>) shares moved upwards by 10.8% to $0.45. The market value of their outstanding shares is at $33.5 million. </li>
<li>SAB Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) stock rose 8.94% to $2.8. The market value of their outstanding shares is at $25.8 million. </li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) shares moved upwards by 8.04% to $1.61. The company's market cap stands at $1.7 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares increased by 7.17% to $0.61. The market value of their outstanding shares is at $1.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock fell 9.9% to $0.12 during Tuesday's after-market session. The company's market cap stands at $3.8 million. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock declined by 9.53% to $2.47. The market value of their outstanding shares is at $13.3 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock decreased by 8.5% to $3.88. The market value of their outstanding shares is at $3.8 million. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) stock decreased by 8.19% to $0.36. The company's market cap stands at $11.4 million. </li>
<li>Sunshine Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) stock decreased by 7.86% to $0.36. The company's market cap stands at $6.8 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares fell 7.82% to $0.52. The company's market cap stands at $3.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBLG

DYNT

ENSC

RDHL

SBFM

12 Health Care Stocks Moving In Tuesday's After-Market Session

BIOLASE To Delist from Nasdaq

<h3>Gainers</h3>
<ul>
<li>Sonoma Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) stock increased by 63.8% to $0.28 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Qualigen Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLGN#NASDAQ">QLGN</a>) stock rose 31.57% to $0.23. The company's market cap stands at $1.4 million. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares rose 30.66% to $0.98. The company's market cap stands at $27.6 million. </li>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) stock rose 25.92% to $1.7. The market value of their outstanding shares is at $32.0 million. </li>
<li>Silk Road Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILK#NASDAQ">SILK</a>) shares moved upwards by 23.9% to $26.85. The market value of their outstanding shares is at $1.0 billion. </li>
<li>Onconetix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) shares moved upwards by 22.73% to $0.2. The market value of their outstanding shares is at $4.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>DermTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMTK#NASDAQ">DMTK</a>) shares fell 50.4% to $0.17 during Tuesday's pre-market session. The company's market cap stands at $5.7 million. </li>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock fell 42.0% to $0.09. The company's market cap stands at $2.8 million. </li>
<li>Zentalis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZNTL#NASDAQ">ZNTL</a>) shares decreased by 28.61% to $5.99. The market value of their outstanding shares is at $425.3 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) stock declined by 15.04% to $0.65. The market value of their outstanding shares is at $1.7 million. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) shares decreased by 12.84% to $0.2. The company's market cap stands at $5.8 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) stock declined by 10.72% to $5.0. The company's market cap stands at $2.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

SCNI

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Shares of Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) fell sharply during Tuesday's session following mix<a href="https://www.benzinga.com/news/earnings/24/05/38814985/alibaba-stock-dips-as-huge-investment-losses-in-q4-overshadow-revenue-growth-and-dividend">ed first-quarter financial results.</a>
The e-commerce giant reported fiscal fourth-quarter 2023 revenue growth of 7% year-on-year to $30.73 billion, beating the analyst consensus estimate of $30.40 billion. Adjusted earnings per ADS of $1.40 missed the analyst consensus estimate of $1.41, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Alibaba Group shares tumbled 6.8% to $78.86 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Cheetah Net Supply Chain Service Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) shares jumped 352.4% to $5.34 as the company reported pricing of $8.19 million follow-on public offering.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) jumped 136% to $0.1434 after jumping over 32% on Monday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) shares gained 73% to $3.4499 after gaining around 18% on Monday.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares gained 72.1% to $8.93 after surging 78% on Monday.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) gained 61.7% to $49.24 after jumping over 74% on Monday.</li>
<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) rose 62% to $4.4590 as high short-interest stocks gain amid the return of trader "Roaring Kitty" to social media. Additionally, the Biden administration raised tariffs on Chinese solar panels.</li>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) gained 52.5% to $3.7693.</li>
<li>Big Lots, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIG#NYSE">BIG</a>) gained 39.7% to $5.18.</li>
<li>Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) jumped 35% to $3.9165 after the company received a conditional commitment for an up to $1.66 billion loan guarantee from the Department of Energy.</li>
<li>Virgin Galactic Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NASDAQ">SPCE</a>) gained 31.5% to $1.3701 as high-short interest stocks gain amid the return of trader &#8216;Roaring Kitty&#8217; to social media.</li>
<li>Vuzix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>) jumped 29.7% to $1.74.</li>
<li>Harrow, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) jumped 29.3% to $15.61 after the company reported first quarter financial results.</li>
<li>Syra Health Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) rose 27.6% to $1.6950 after the company that it is a subcontracts for LUKE on a 10-year $43 billion Defense Health Agency contract.</li>
<li>Beyond Meat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) rose 27% to $10.14 after retail investor Roaring Kitty made a return to social media on Monday via a post on X.</li>
<li>Delcath Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) gained 25.5% to $6.80 following upbeat quarterly results.</li>
<li>Tupperware Brands Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUP#NYSE">TUP</a>) jumped 25% to $2.20 after retail investor Roaring Kitty made a return to social media on Monday via a post on X.</li>
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) gained 23.8% to $5.14 after the Biden administration raised tariffs on Chinese solar panels.</li>
<li>Paysafe Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSFE#NYSE">PSFE</a>) gained 23.6% to $19.37 as the company posted better-than-expected results for its first quarter.</li>
<li>AMTD Digital Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HKD#NYSE">HKD</a>) gained 24.4% to $4.5191.</li>
<li>Hertz Global Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NYSE">HTZ</a>) rose 19.7% to $6.55.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) gained 18.4% to $3.67 after adding around 7% on Monday.</li>
<li>SmartRent, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) rose 17.5% to $2.82 after Land &amp; Buildings sent a letter to the Board urging the exploration of strategic alternatives.</li>
<li>Fossil Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSL#NASDAQ">FOSL</a>) rose 17.4% to $1.2101.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) gained 16.7% to $3.61 after retail investor Roaring Kitty made a return to social media on Monday via a post on X.</li>
<li>Uxin Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NASDAQ">UXIN</a>) rose 16.6% to $3.78.</li>
<li>Dawson Geophysical Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWSN#NASDAQ">DWSN</a>) jumped 15.8% to $1.68 following first-quarter results.</li>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) rose 15.4% to $6.08.</li>
<li>Clover Health Investments, Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) gained 15% to $1.04.</li>
<li>On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) gained 14.7% to $35.21 after the company reported better-than-expected first-quarter financial results.</li>
<li>Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) gained 14.5% to $91.89 after the company reported better-than-expected quarterly financial results.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) gained 11.6% to $1.9983.</li>
<li>Alcon Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) gained 9.6% to $88.47 following better-than-expected first-quarter earnings.</li>
<li>Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares rose 9.6% to $2.18.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) gained 9.5% to $12.65.</li>
<li>Rent the Runway, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) shares rose 7.4% to $21.45 after gaining over 12% on Monday.</li>
<li>Sony Group Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) gained 6.3% to $80.95 after the company reported better-than-expected quarterly financial results</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Scorpius Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NASDAQ">SCPX</a>) fell 54.8% to $0.0820 after the company reported pricing of public offering.</li>
<li>Augmedix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUGX#NASDAQ">AUGX</a>) shares fell 50.7% to $1.1596 after the company reported first-quarter financial results.</li>
<li>Inotiv, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) fell 46.8% to $2.22 after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $11.5 to $3.75.</li>
<li>Akoya Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) fell 28.3% to $2.9550 after the company reported worse-than-expected first-quarter financial results and lowered its FY24 revenue forecast.</li>
<li>Eastside Distilling, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) dipped 26% to $1.0950 following first-quarter earnings.</li>
<li>JanOne Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAN#NASDAQ">JAN</a>) fell 23.8% to $2.9443.</li>
<li>Shimmick Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHIM#NASDAQ">SHIM</a>) declined 23.6% to $2.78 following weak quarterly earnings.</li>
<li>Fennec Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>) fell 23.2% to $7.70 following quarterly results.</li>
<li>BIOLASE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) shares fell 15.3% to $0.1532 after the company reported mixed first-quarter financial results.</li>
<li>IHS Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHS#NYSE">IHS</a>) declined 15.2% to $3.2650 following first-quarter results.</li>
<li>Jamf Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) fell 12.1% to $17.95 after the company announced the pricing of a secondary offering by selling stockholders.</li>
<li>Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) declined 10.7% to $42.51 after the company priced a 2.4 million share offering at $43 per share.</li>
<li>INVO Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) shares fell 9.8% to $1.10 after jumping over 20% on Monday.</li>
<li>StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) shares declined 9.6% to $15.04 after the company reported first-quarter financial results.</li>
<li>TeraWulf Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) shares fell 9.4% to $2.03 after the company reported downbeat results for its first quarter on Monday.</li>
<li>Better Home &amp; Finance Holding Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BETR#NASDAQ">BETR</a>) declined 7.1% to $0.4135 following first-quarter results.</li>
<li>VinFast Auto Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFS#NASDAQ">VFS</a>) fell 6% to $4.29.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38815957/planet-fitness-to-rally-around-19-here-are-10-top-analyst-forecasts-for-tuesday">Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday</a>

Intraday Update

Markets

AGYS

AKYA

AUGX

BABA

BETR

BYND

CLOV

CTNT

DCTH

DWSN

EAST

FENC

FFIE

FOSL

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

INVO

JAMF

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MBIN

NOTV

NOVA

ONON

PLUG

PSFE

RENT

SCPX

SHIM

SMRT

Sony Group Corporation American Depositary Shares

SONY

SPCE

SPWR

STNE

SYRA

TLRY

UXIN

VUZI

WOOF

WULF

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Delcath Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) stock rose 33.2% to $7.19 during Tuesday's regular session. The company's market cap stands at $199.8 million. As per the news, the Q1 earnings report came out today. </li>
<li>Harrow (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) stock rose 32.64% to $16.01. The company's market cap stands at $566.4 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) shares moved upwards by 26.29% to $3.89. The company's market cap stands at $248.6 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Sunshine Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) stock rose 25.14% to $1.09. The market value of their outstanding shares is at $1.0 million. </li>
<li>Pacific Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) stock moved upwards by 22.02% to $2.35. The company's market cap stands at $641.3 million. As per the press release, Q1 earnings came out 3 days ago. </li>
<li>Generation Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBIO#NASDAQ">GBIO</a>) stock rose 20.77% to $3.43. The market value of their outstanding shares is at $228.0 million. As per the press release, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) stock declined by 52.1% to $0.09 during Tuesday's regular session. The company's market cap stands at $3.1 million. </li>
<li>Augmedix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUGX#NASDAQ">AUGX</a>) shares declined by 50.0% to $1.17. The market value of their outstanding shares is at $57.2 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) stock declined by 48.09% to $2.17. The company's market cap stands at $55.8 million. </li>
<li>Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) stock decreased by 31.44% to $2.83. The company's market cap stands at $139.4 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares declined by 18.1% to $2.49. The company's market cap stands at $2.9 million. The company's, Q1 earnings came out yesterday. </li>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock declined by 16.81% to $0.15. The market value of their outstanding shares is at $5.0 million. As per the press release, Q1 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GBIO

PACB

PROK

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benchmark analyst Bruce Jackson reiterates Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) with a Speculative Buy and maintains $0.4 price target.

Shares of Alcon Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) rose sharply in today's pre-market trading following better-than-expected <a href="https://www.benzinga.com/quote/ALC/earnings">first-quarter earnings.</a>
Alcon posted adjusted earnings of 78 cents per share, beating market expectations of 63 cents per share. The company's quarterly sales came in at $2.444 billion versus estimates of $2.462 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Alcon shares jumped 10.8% to $89.40 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) gained 40.2% to $42.70 in pre-market trading after jumping over 74% on Monday.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) gained 39.2% to $0.0849 in pre-market trading after jumping over 32% on Monday.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares gained 38.3% to $7.18 in pre-market trading after surging 78% on Monday.</li>
<li>Warrantee Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRNT#NASDAQ">WRNT</a>) rose 31.6% to $0.41 in today's pre-market trading.</li>
<li>MicroCloud Hologram Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) shares gained 31% to $2.62 in pre-market trading after gaining around 18% on Monday.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) gained 25.2% to $3.88 in pre-market trading after adding around 7% on Monday.</li>
<li>Rent the Runway, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) shares rose 19.2% to $23.80 in pre-market trading after gaining over 12% on Monday.</li>
<li>Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares rose 14.1% to $2.27 in pre-market trading.</li>
<li>Paysafe Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSFE#NYSE">PSFE</a>) gained 13% to $17.70 in pre-market trading as the company posted better-than-expected results for its first quarter.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Augmedix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUGX#NASDAQ">AUGX</a>) shares dipped 34.2% to $1.54 in pre-market trading after the company reported first-quarter financial results.</li>
<li>Inotiv, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) shares fell 30.2% to $2.91 pre-market trading after gaining over 10% on Monday</li>
<li>Akoya Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) dipped 20.6% to $3.27 in pre-market trading after the company reported worse-than-expected first-quarter financial results and lowered its FY24 revenue forecast.</li>
<li>Scorpius Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NYSE">SCPX</a>) shares fell 17.4% to $0.15 in pre-market trading. Scorpius Holdings, last week, announced the appointment of Shari Udoff-McDonald as VP of Business Development.</li>
<li>INVO Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) shares declined 13.1% to $1.06 in pre-market trading after jumping over 20% on Monday.</li>
<li>BIOLASE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) shares fell 11.6% to $0.1598 in pre-market trading after the company reported mixed first-quarter financial results.</li>
<li>StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) shares declined 9.3% to $15.10 in pre-market trading after the company reported first-quarter financial results.</li>
<li>TeraWulf Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) shares fell 9.3% to $2.03 in pre-market trading after the company reported downbeat results for its first quarter on Monday.</li>
<li>TMC the metals company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) shares fell 8.6% to $1.39 in pre-market trading after the company reported first-quarter financial results.</li>
<li>Applied DNA Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares dipped 8.2% to $2.83 in pre-market trading. Applied DNA Sciences shares fell 12% on Monday after the company reported worse-than-expected second-quarter financial results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38807221/home-depot-paysafe-and-3-stocks-to-watch-heading-into-tuesday">Home Depot, Paysafe And 3 Stocks To Watch Heading Into Tuesday</a>

Pre-Market Outlook

Trading Ideas

APDN

WRNT

Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Biolase shares are trading higher after the company reported mixed Q1 financial results.

Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.17) by 111.76 percent. The company reported quarterly sales of $10.131 million which beat the analyst consensus estimate of $9.996 million by 1.35 percent. This is a 3.21 percent decrease over sales of $10.467 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Biolase Q1 2024 Adj EPS $(0.36) Misses $(0.17) Estimate, Sales $10.131M Beat $9.996M Estimate

<h3>Gainers</h3>
<ul>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands at $18.9 million. </li>
<li>Ocuphire Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUP#NASDAQ">OCUP</a>) stock rose 7.82% to $1.93. The company's market cap stands at $47.8 million. </li>
<li>Lyell Immunopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYEL#NASDAQ">LYEL</a>) stock rose 7.5% to $2.86. The market value of their outstanding shares is at $726.5 million. </li>
<li>iSpecimen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) shares rose 6.38% to $0.24. The market value of their outstanding shares is at $2.1 million. </li>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) shares moved upwards by 5.89% to $0.16. The company's market cap stands at $1.9 million. </li>
<li>Bright Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGXX#NASDAQ">BGXX</a>) shares moved upwards by 5.0% to $0.25. The market value of their outstanding shares is at $46.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Motus GI Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOTS#NASDAQ">MOTS</a>) stock declined by 32.6% to $0.28 during Thursday's after-market session. The market value of their outstanding shares is at $1.4 million. </li>
<li>Acorda Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOR#NASDAQ">ACOR</a>) stock declined by 17.55% to $0.55. </li>
<li>Nurix Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>) shares decreased by 9.36% to $15.6. The company's market cap stands at $766.7 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock declined by 5.9% to $0.14. The company's market cap stands at $4.5 million. </li>
<li>Entrada Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRDA#NASDAQ">TRDA</a>) stock fell 5.59% to $12.52. The market value of their outstanding shares is at $420.6 million. </li>
<li>Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) stock declined by 5.26% to $5.05. The company's market cap stands at $1.3 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACOR

AKAN

AUTL

BGXX

ISPC

LYEL

MOTS

NRIX

OCUP

OTRK

TRDA

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Rallybio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>) shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. </li>
<li>Vera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) shares increased by 10.52% to $46.0. The market value of their outstanding shares is at $2.5 billion. </li>
<li>Biophytis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTS#NASDAQ">BPTS</a>) stock rose 9.49% to $0.37. The company's market cap stands at $4.2 million. </li>
<li>IMAC Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BACK#NASDAQ">BACK</a>) shares rose 7.35% to $3.02. The company's market cap stands at $3.4 million. </li>
<li>Relay Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLAY#NASDAQ">RLAY</a>) stock moved upwards by 7.1% to $7.39. The company's market cap stands at $969.4 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) shares rose 6.43% to $2.48. The company's market cap stands at $10.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CytomX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) stock fell 7.2% to $1.95 during Wednesday's after-market session. The market value of their outstanding shares is at $132.0 million. </li>
<li>Orgenesis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGS#NASDAQ">ORGS</a>) shares declined by 5.74% to $0.49. The company's market cap stands at $16.7 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares fell 4.81% to $0.64. The market value of their outstanding shares is at $20.6 million. </li>
<li>Fate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) shares fell 4.31% to $6.0. The market value of their outstanding shares is at $682.6 million. </li>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock decreased by 3.94% to $0.15. The company's market cap stands at $4.9 million. </li>
<li>ABVC BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>) stock decreased by 3.46% to $1.1. The company's market cap stands at $11.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABVC

ADIL

BACK

BPTS

CTMX

FATE

ONMD

ORGS

RLAY

RLYB

VERA

Ascendiant Capital analyst Edward Woo maintains Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) with a Buy and lowers the price target from $15 to $4.

Ascendiant Capital Maintains Buy on Biolase, Lowers Price Target to $4

Shares of Cutera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cutr#NASDAQ">CUTR</a>) fell sharply during Friday&rsquo;s session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/CUTR/earnings">fourth quarter adjusted EPS results</a>.
Cutera posted adjusted loss of $1.36 per share, compared to market estimates for a loss of 94 cents per share. The company&rsquo;s quarterly sales came in at $49.540 million, versus expectations of $47.500 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Cutera shares dipped 26.5% to $1.6899 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Murano Global Investments PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) shares jumped 147.5% to $23.94 after falling 46% on Thursday.</li>
<li>Nova LifeStyle, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvfy#NASDAQ">NVFY</a>) surged 120% to $4.0301 after gaining around 22% on Thursday.</li>
<li>BIOLASE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biol#NASDAQ">BIOL</a>) shares climbed 50.4% to $0.2256 after the company reported better-than-expected fourth-quarter earnings results.</li>
<li>IMAC Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/back#NASDAQ">BACK</a>) gained 41.1% to $1.8204.</li>
<li>Summit Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smlp#NYSE">SMLP</a>) surged 36.1% to $26.45 after the company announced the sale of its Utica position for $625 million.</li>
<li>Outlook Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otlk#NASDAQ">OTLK</a>) gained 32.1% to $9.30 after the company announced it received a positive European Union CHMP opinion for ONS-5010 as a treatment for Wet AMD.</li>
<li>GT Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtbp#NASDAQ">GTBP</a>) gained 27.6% to $4.86.</li>
<li>Aemetis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amtx#NASDAQ">AMTX</a>) rose 21% to $6.21. Aemetis recently announced approval by the U.S. Citizenship and Immigration Services for a $200 million of EB-5 program investment for the Riverbank sustainable aviation fuel, production plant, the dairy renewable natural gas project, the carbon sequestration project and energy efficiency upgrades to the Keyes ethanol plant.</li>
<li>Foresight Autonomous Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frsx#NASDAQ">FRSX</a>) gained 20.4% to $1.1796. Foresight Autonomous said Eye-Net and Softbank completed technology validation phase for connected mobility applications in Japan.</li>
<li>Intellicheck, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idn#NASDAQ">IDN</a>) gained 19.4% to $2.09 after the company reported a year-over-year increase in fourth-quarter EPS results.</li>
<li>Worthington Steel, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ws#NYSE">WS</a>) climbed 18.8% to $37.92 as the company posted stronger-than-expected results for its third quarter on Thursday.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) rose 18.6% to $5.41.</li>
<li>Annexon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/annx#NASDAQ">ANNX</a>) climbed 17.3% to $7.14.</li>
<li>Ocugen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocgn#NASDAQ">OCGN</a>) gained 12.5% to $1.5090 after gaining 8% on Thursday. Ocugen recently appointed Huma Qamar, MD, MPH as Chief Medical Officer.</li>
<li>Lithium Americas (Argentina) Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/laac#NYSE">LAAC</a>) rose 12.2% to $5.77.</li>
<li>Dianthus Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnth#NASDAQ">DNTH</a>) surged 11% to $30.84 following upbeat results.</li>
<li>Griid Infrastructure Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grdi#NASDAQ">GRDI</a>) gained 10.9% to $1.22.</li>
<li>Astera Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alab#NASDAQ">ALAB</a>) rose 9.6% to $70.30.</li>
<li>FedEx Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fdx#NYSE">FDX</a>) rose gained 7.9% to $285.78 after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion share repurchase program.</li>
<li>Foot Locker, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fl#NYSE">FL</a>) rose 5% to $24.85. Citigroup analyst Paul Lejuez upgraded Foot Locker from Sell to Neutral and announced a $24 price target.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) shares fell 36.4% to $2.32. BYND Cannasoft said that the previously announced 1-for-190 reverse stock split of its outstanding shares of common stock has been made effective today, March 22, 2024.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) fell 30.4% to $0.0946 after the company announced a proposed public offering of common stock.</li>
<li>Ispire Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ispr#NASDAQ">ISPR</a>) fell 28% to $5.84 after the company announced the pricing of its public offering of 2.05 million shares of common stock at $6.00 per share.</li>
<li>Brand Engagement Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnai#NASDAQ">BNAI</a>) declined 27.2% to $8.00.</li>
<li>Nkarta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktx#NASDAQ">NKTX</a>) fell 22.2% to $10.10 after the company reported fourth-quarter financial results. Following earnings, Raymond James downgraded the stock from Strong Buy to Outperform.</li>
<li>Yield10 Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yten#NASDAQ">YTEN</a>) fell 22.7% to $0.3358. Yield10 Bioscience recently announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States.</li>
<li>ReTo Eco-Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) declined 20% to $1.50.</li>
<li>Aterian, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ater#NASDAQ">ATER</a>) fell 18.3% to $2.66.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxeh#NASDAQ">LXEH</a>) dipped 18% to $0.6026.</li>
<li>Lululemon Athletica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>) tumbled 16.6% to $399.36. Lululemon posted better-than-expected results for its fourth quarter, but issued a weak forecast for the first quarter.</li>
<li>TROOPS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/troo#NASDAQ">TROO</a>) declined 16.3% to $1.3798.</li>
<li>Li-Cycle Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/licy#NYSE">LICY</a>) dipped 14% to $1.1096.</li>
<li>Cazoo Group Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/czoo#NYSE">CZOO</a>) fell 13.8% to $4.0480.</li>
<li>Selina Hospitality PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slna#NASDAQ">SLNA</a>) fell 12.9% to $0.2439 after jumping around 30% on Thursday.</li>
<li>Grifols, S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grfs#NASDAQ">GRFS</a>) fell 11.3% to $6.01.</li>
<li>Abits Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abts#NASDAQ">ABTS</a>) dipped 9.9% to $0.6991 after declining over 6% on Thursday.</li>
<li>Bitdeer Technologies Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btdr#NASDAQ">BTDR</a>) fell 9.8% to $7.17.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) fell 9.2% to $3.2950.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) shares fell 9% to $0.0458 after dipping 16% on Thursday.</li>
<li>NIKE, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nke#NYSE">NKE</a>) shares tumbled 8.1% to $92.63. Nike reported upbeat earnings and sales results for its third quarter on Thursday.</li>
<li>JOANN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/joan#NASDAQ">JOAN</a>) shares fell 7.8% to $0.1420 after surging 14% on Thursday.</li>
<li>AAR Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/air#NYSE">AIR</a>) fell 5.9% to $60.14 following downbeat sales.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37891280/bitcoin-falls-below-65-000-ondo-solana-among-top-losers"> Bitcoin Falls Below $65,000; Ondo, Solana Among Top Losers </a>

Penny Stocks

Small Cap

ABTS

ALAB

AMTX

ANNX

ATER

BCAN

BNAI

BTDR

CUTR

CZOO

DNTH

EGOX

FRSX

GRDI

GRFS

GTBP

ISPR

JOAN

LAAC

LICY

LULU

LXEH

MRNO

NKTX

NVFY

OCGN

OTLK

RETO

SINT

SLNA

SMLP

TROO

YTEN

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benchmark analyst Bruce Jackson maintains Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) with a Speculative Buy and lowers the price target from $2.5 to $0.4.

Benchmark Maintains Speculative Buy on Biolase, Lowers Price Target to $0.4

Biolase GAAP EPS of -$0.36 misses by $0.19, revenue of $10.13M beats by $0.13M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Biolase (NASDAQ:<a href="https://investorplace.com/stock-quotes/biol-stock-quote/">BIOL</a>) just reported results for the first quarter of 2024.<ul><li>Biolase reported earnings per share of -20 cents. This was below the analyst estimate for EPS of -17 cents.</li><li>The company reported revenue of $10.13 million.</li><li>This was 1.31% better than the analyst estimate for revenue of $10.00 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/biol-stock-earnings-biolase-for-q1-of-2024/">BIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024

BIOLASE, Inc. (BIOL) Q1 2024 Earnings Call Transcript

Biolase (BIOL – Research Report) received a Hold rating and price target from Maxim Group analyst Anthony Vendetti yesterday. The company's shares ...

Maxim Group downgrades Biolase (BIOL) to a Hold

Ascendiant analyst Edward Woo maintained a Buy rating on Biolase (BIOL – Research Report) on June 1 and set a price target of $3.50. Edward Woo has...

Biolase Buy Rating Affirmed Amid Growth Opportunities and Proactive Cost Management

Comments

Biolase Inc COM PAR $.001 NEW

Notizie

Ultime notizie per Biolase Inc COM PAR $.001 NEW (OTC:BIOL) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO